Zhengye Biotechnology (NASDAQ:ZYBT) Shares Up 0.7% – Still a Buy?

Shares of Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) were up 0.7% during trading on Thursday. The company traded as high as $1.50 and last traded at $1.43. Approximately 24,492 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 1,753,097 shares. The stock had previously closed at $1.42.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Zhengye Biotechnology in a research note on Friday, October 16th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Zhengye Biotechnology currently has a consensus rating of “Sell”.

Zhengye Biotechnology Trading Down 9.1%

The firm’s 50-day moving average price is $1.48 and its 200-day moving average price is $1.16.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Group Co, Ltd. is a China-based biotechnology company focused on developing, manufacturing and selling biological products for the agricultural and animal husbandry industries. Its business is centered on applying microbial technologies to support animal health, livestock production and crop cultivation.

The company’s product offerings include microbial-based products used in animal feed and agricultural production, as well as related biological solutions intended to improve farming efficiency and promote healthier livestock and crops.